Cargando…

Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes

A unique feature of thymomas is their unrivaled frequency of associated myasthenia gravis (MG). Previous studies reported that MG+ thymomas contain a larger number of mature “pre-emigrant” CD4+ T cells than MG- thymomas and that most thymomas do not contain AIRE expressing cells irrespective of MG s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yosuke, Weis, Cleo-Aron, Thelen, Julian, Sticht, Carsten, Schalke, Berthold, Ströbel, Philipp, Marx, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176899/
https://www.ncbi.nlm.nih.gov/pubmed/32373124
http://dx.doi.org/10.3389/fimmu.2020.00664
_version_ 1783525097267527680
author Yamada, Yosuke
Weis, Cleo-Aron
Thelen, Julian
Sticht, Carsten
Schalke, Berthold
Ströbel, Philipp
Marx, Alexander
author_facet Yamada, Yosuke
Weis, Cleo-Aron
Thelen, Julian
Sticht, Carsten
Schalke, Berthold
Ströbel, Philipp
Marx, Alexander
author_sort Yamada, Yosuke
collection PubMed
description A unique feature of thymomas is their unrivaled frequency of associated myasthenia gravis (MG). Previous studies reported that MG+ thymomas contain a larger number of mature “pre-emigrant” CD4+ T cells than MG- thymomas and that most thymomas do not contain AIRE expressing cells irrespective of MG status. These findings suggest that CD4+ T cells that mature inside the abnormal microenvironment of thymomas and egress to the blood are critical to the development of thymoma-associated MG (TAMG) irrespective of thymoma histotype. However, underlying mechanisms have remained enigmatic. To get hints to mechanisms underlying TAMG, we pursue three hypotheses: (i) Functional pathways with metabolic and immunological relevance might be differentially expressed in TAMG(+) compared to TAMG(-) thymomas; (ii) differentially enriched pathways might be more evident in immature lymphocyte-poor (i.e., tumor cell/stroma-rich) thymoma subgroups; and (iii) mechanisms leading to TAMG might be different among thymoma histological subtypes. To test these hypotheses, we compared the expression of functional pathways with potential immunological relevance (N = 380) in relation to MG status separately in type AB and B2 thymomas and immature lymphocyte-rich and lymphocyte-poor subgroups of these thymoma types using the TCGA data set. We found that <10% of the investigated pathways were differentially upregulated or downregulated in MG+ compared to MG- thymomas with significant differences between AB and B2 thymomas. The differences were particularly evident, when epithelial cell/stroma-rich subsets of type AB and B2 thymomas were analyzed. Unexpectedly, some MG-associated pathways that were significantly upregulated in AB thymomas were significantly downregulated in B2 thymomas, as exemplified by the oxidative phosphorylation pathway. Conversely, the MG-associated pathway related to macrophage polarization was downregulated in MG+ AB thymoma and upregulated in MG+ B2 thymoma. We conclude that functional pathways are significantly associated with TAMG, and that some mechanisms leading to TAMG might be different among thymoma histological subtypes. Functions related to metabolisms, vascular and macrophage biology are promising new candidate mechanisms potentially involved in the pathogenesis of TAMG. More generally, the results imply that future studies addressing pathomechanisms of TAMG should take the histotype and abundance of tumor cells and non-neoplastic stromal components of thymomas into account.
format Online
Article
Text
id pubmed-7176899
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71768992020-05-05 Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes Yamada, Yosuke Weis, Cleo-Aron Thelen, Julian Sticht, Carsten Schalke, Berthold Ströbel, Philipp Marx, Alexander Front Immunol Immunology A unique feature of thymomas is their unrivaled frequency of associated myasthenia gravis (MG). Previous studies reported that MG+ thymomas contain a larger number of mature “pre-emigrant” CD4+ T cells than MG- thymomas and that most thymomas do not contain AIRE expressing cells irrespective of MG status. These findings suggest that CD4+ T cells that mature inside the abnormal microenvironment of thymomas and egress to the blood are critical to the development of thymoma-associated MG (TAMG) irrespective of thymoma histotype. However, underlying mechanisms have remained enigmatic. To get hints to mechanisms underlying TAMG, we pursue three hypotheses: (i) Functional pathways with metabolic and immunological relevance might be differentially expressed in TAMG(+) compared to TAMG(-) thymomas; (ii) differentially enriched pathways might be more evident in immature lymphocyte-poor (i.e., tumor cell/stroma-rich) thymoma subgroups; and (iii) mechanisms leading to TAMG might be different among thymoma histological subtypes. To test these hypotheses, we compared the expression of functional pathways with potential immunological relevance (N = 380) in relation to MG status separately in type AB and B2 thymomas and immature lymphocyte-rich and lymphocyte-poor subgroups of these thymoma types using the TCGA data set. We found that <10% of the investigated pathways were differentially upregulated or downregulated in MG+ compared to MG- thymomas with significant differences between AB and B2 thymomas. The differences were particularly evident, when epithelial cell/stroma-rich subsets of type AB and B2 thymomas were analyzed. Unexpectedly, some MG-associated pathways that were significantly upregulated in AB thymomas were significantly downregulated in B2 thymomas, as exemplified by the oxidative phosphorylation pathway. Conversely, the MG-associated pathway related to macrophage polarization was downregulated in MG+ AB thymoma and upregulated in MG+ B2 thymoma. We conclude that functional pathways are significantly associated with TAMG, and that some mechanisms leading to TAMG might be different among thymoma histological subtypes. Functions related to metabolisms, vascular and macrophage biology are promising new candidate mechanisms potentially involved in the pathogenesis of TAMG. More generally, the results imply that future studies addressing pathomechanisms of TAMG should take the histotype and abundance of tumor cells and non-neoplastic stromal components of thymomas into account. Frontiers Media S.A. 2020-04-16 /pmc/articles/PMC7176899/ /pubmed/32373124 http://dx.doi.org/10.3389/fimmu.2020.00664 Text en Copyright © 2020 Yamada, Weis, Thelen, Sticht, Schalke, Ströbel and Marx. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yamada, Yosuke
Weis, Cleo-Aron
Thelen, Julian
Sticht, Carsten
Schalke, Berthold
Ströbel, Philipp
Marx, Alexander
Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes
title Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes
title_full Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes
title_fullStr Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes
title_full_unstemmed Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes
title_short Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes
title_sort thymoma associated myasthenia gravis (tamg): differential expression of functional pathways in relation to mg status in different thymoma histotypes
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176899/
https://www.ncbi.nlm.nih.gov/pubmed/32373124
http://dx.doi.org/10.3389/fimmu.2020.00664
work_keys_str_mv AT yamadayosuke thymomaassociatedmyastheniagravistamgdifferentialexpressionoffunctionalpathwaysinrelationtomgstatusindifferentthymomahistotypes
AT weiscleoaron thymomaassociatedmyastheniagravistamgdifferentialexpressionoffunctionalpathwaysinrelationtomgstatusindifferentthymomahistotypes
AT thelenjulian thymomaassociatedmyastheniagravistamgdifferentialexpressionoffunctionalpathwaysinrelationtomgstatusindifferentthymomahistotypes
AT stichtcarsten thymomaassociatedmyastheniagravistamgdifferentialexpressionoffunctionalpathwaysinrelationtomgstatusindifferentthymomahistotypes
AT schalkeberthold thymomaassociatedmyastheniagravistamgdifferentialexpressionoffunctionalpathwaysinrelationtomgstatusindifferentthymomahistotypes
AT strobelphilipp thymomaassociatedmyastheniagravistamgdifferentialexpressionoffunctionalpathwaysinrelationtomgstatusindifferentthymomahistotypes
AT marxalexander thymomaassociatedmyastheniagravistamgdifferentialexpressionoffunctionalpathwaysinrelationtomgstatusindifferentthymomahistotypes